Associated Papers
The Impact of PCSK9 on Diabetic Cardiomyopathy: Mechanisms and Implications.
Wang H et al.
Biomolecules, 2025
An intron mutation of HNF1A causes abnormal splicing and impairs its activity as a transcription factor.
Wang M et al.
Molecular and Cellular Endocrinology, 2022
HNF1A：From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus.
Li LM et al.
Frontiers in Endocrinology, 2022
Maturity Onset Diabetes of the Young-New Approaches for Disease Modelling.
Skoczek D et al.
International Journal of Molecular Sciences, 2021
34299172 (PubMed )
Supplement: ijms-22-07553-s001.zip › ijms-1265050-supplementary.xlsx › Arkusz1
A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin.
Shepherd MH et al.
Diabetologia, 2018
30229274 (PubMed )
Supplement: 125_2018_4728_MOESM1_ESM.pdf
Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.
Bacon S et al.
Diabetic Medicine : a Journal of the British Diabetic Association, 2016
Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors.
Fendler W et al.
Diabetologia, 2016
27059371 (PubMed )
Supplement: 125_2016_3945_MOESM2_ESM.pdf
Improved genetic testing for monogenic diabetes using targeted next-generation sequencing.
Ellard S et al.
Diabetologia, 2013
Identification of circulating microRNAs in HNF1A-MODY carriers.
Bonner C et al.
Diabetologia, 2013
Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.
Kyithar MP et al.
Journal of Translational Medicine, 2013
Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
Colclough K et al.
Human Mutation, 2013
Serum levels of pancreatic stone protein (PSP)/reg1A as an indicator of beta-cell apoptosis suggest an increased apoptosis rate in hepatocyte nuclear factor 1 alpha (HNF1A-MODY) carriers from the third decade of life onward.
Bacon S et al.
Bmc Endocrine Disorders, 2012
Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
Kyithar MP et al.
Diabetes & Metabolism, 2011
The HNF-1alpha-SNARE connection.
Yamagata K et al.
Diabetes, Obesity & Metabolism, 2007
Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
Ellard S et al.
Human Mutation, 2006
Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients.
Xu JY et al.
European Journal of Human Genetics : Ejhg, 2005
Select a paper to view details